Home/Filings/4/0001209191-21-008585
4//SEC Filing

Kopczynski Casey C. 4

Accession 0001209191-21-008585

CIK 0001337553other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 6:05 PM ET

Size

7.4 KB

Accession

0001209191-21-008585

Insider Transaction Report

Form 4
Period: 2021-02-04
Kopczynski Casey C.
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-02-04+11,000207,114 total
  • Award

    Stock Option (right to buy)

    2021-02-04+50,00050,000 total
    Exercise: $17.64Exp: 2031-02-04Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 4, 2021.
  • [F2]The option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 4, 2021.

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1
  • filerCIK 0001590001

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 6:05 PM ET
Size
7.4 KB